Cited by 8Alzheimer's disease research and treatmentsProtein purification and stabilityLipoproteins and Cardiovascular Health

Apolipoprotein E Expression and Purification

Newhouse, Yvonne, Weisgraber, Karl H.·2010·Methods in Molecular Biology

Abstract

Since the discovery of the association of apolipoprotein E (apoE) 4 with Alzheimer's disease 17 years ago, numerous in vitro experiments with the apoE isoforms (apoE2, apoE3, and apoE4) have been performed to try to understand the basis for this association. The majority of these studies used commercial sources for apoE, but some used recombinant protein. In either case, these studies were most often conducted without considering the ramifications of the structural and biophysical differences among the three isoforms or without adequate quality control of the preparations. Here, we present a protocol for producing recombinant apoE that we have used successfully in our laboratory for the last 20 years. We also review the considerations that are critical for obtaining reliable and interpretable results with the end product.

Integrity signals

Registry

Crossref · 10.1007/978-1-60761-744-0_10

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Bacterial ApoE is expressed as inclusion bodies that must be denatured, refolded, and optionally converted into LNPs using non-physiological procedures.

    “Bacterial ApoE is expressed as inclusion bodies that must be denatured, refolded, and optionally converted into LNPs using non-physiological procedures, resulting in holoprotein that is different from its brain-derived counterpart with respect to key physical (e.g., lipid composition) and/or chemical (e.g., post-translational modifications) properties.21”
  • Bacterial ApoE holoprotein is different from its brain-derived counterpart with respect to key physical and/or chemical properties.

    “resulting in holoprotein that is different from its brain-derived counterpart with respect to key physical (e.g., lipid composition) and/or chemical (e.g., post-translational modifications) properties.21”
  • To date all reports describing the biochemical properties of this recombinant protein have deployed lipid-free biosynthetic materials.

    “Although ApoE is not detected in appreciable quantities in its apo form in physiological fluids, to date all reports describing the biochemical properties of this recombinant protein have deployed lipid-free biosynthetic materials.21–25”
  • ApoE is not detected in appreciable quantities in its apo form in physiological fluids.

    “Although ApoE is not detected in appreciable quantities in its apo form in physiological fluids, to date all reports describing the biochemical properties of this recombinant protein have deployed lipid-free biosynthetic materials.21–25”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Newhouse, Y., & Weisgraber, K. H.
Affiliations
University of California, San Francisco (US)
Venue
Methods in Molecular Biology
Publisher
Humana Press
Published
2010
Volume
670
Pages
127-140
ISSN
  • 1064-3745 (ISSN-L)
  • 1940-6029
OpenAlex
W2404122114
Cited by
8
References
3
Citations by year
2026: 1 · 2025: 1 · 2023: 1 · 2022: 1 · 2014: 2 · 2012: 1
FWCI
2.15
Type
book chapter
Language
en
Open access
closed
Locations
  • Methods in molecular biology (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute on Aging (R01AG028793)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein purification and stability
  • Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
Keywords
apolipoprotein E, recombinant protein expression, protein purification, APOE isoforms, APOE ε4, Alzheimer's disease, protein quality control
MeSH terms
Alzheimer Disease, Apolipoproteins E, Bacteria, Chromatography, Gel, Electrophoresis, Polyacrylamide Gel, Recombinant Proteins, Apolipoprotein E3, Apolipoprotein E4, Apolipoprotein E2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review